| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 08/24/2006 | CA2598897A1 Fungicidal pyrazine derivatives |
| 08/24/2006 | CA2598076A1 Chemical compounds |
| 08/24/2006 | CA2597896A1 1h-imidazole derivatives as cannabinoid cb2 receptor modulators |
| 08/24/2006 | CA2597813A1 Chemical compounds |
| 08/24/2006 | CA2597594A1 Azolylacylguanidines as beta-secretase inhibitors |
| 08/24/2006 | CA2597033A1 1,5-diarylpyrrole derivatives, preparation method thereof and application of same in therapeutics |
| 08/23/2006 | EP1693372A1 Novel Sulfamides and their use as endothelin receptor antagonists |
| 08/23/2006 | EP1693365A1 Inhibitors of dipeptidyl peptidase IV |
| 08/23/2006 | EP1692129A1 Keto lactam compounds and use thereof |
| 08/23/2006 | EP1692128A1 Indazole compounds and methods of use thereof as protein kinase inhibitors |
| 08/23/2006 | EP1692116A1 1,2,3-triazole amide derivatives as inhibitors of cytokine production |
| 08/23/2006 | EP1692114A1 Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament |
| 08/23/2006 | EP1692113A1 Aryl imidazoles and their use as anti-cancer agents |
| 08/23/2006 | EP1691810A1 Substituted piperazines |
| 08/23/2006 | EP1691803A1 N-alkyl pyrroles as hmg-coa reductase inhibitors |
| 08/23/2006 | EP1633346B1 Pyrrolidin-1, 2- dicarboxylic acid- 1- (4- ethinyl- phenyl) - amid|- 2- (phenyl)- amid| derivative as inhibitors of coagulation factor xa and viia for the treatment of thrombosis |
| 08/23/2006 | CN1823063A Quinoline derivatives as phosphodiesterase inhibitors |
| 08/23/2006 | CN1823060A Improved process for preparing alpha-polymorphic eletriptan hydrobromide |
| 08/23/2006 | CN1823059A Selective D1/dD receptor antagonists for the treatment of obesity and CNS disorders |
| 08/23/2006 | CN1823057A Biaryl piperazinyl-pyridine analogues |
| 08/23/2006 | CN1823056A Trisubstituted aryl and heteroaryl derivatives as modulatorsof metabolism and the prophylaxis and treatment of disorders related thereto |
| 08/23/2006 | CN1823048A Substituted pyrimidin-4-ylamina analogues as vanilloid receptor ligands |
| 08/23/2006 | CN1823043A Hydroxypyridine cgrp receptor antagonists |
| 08/23/2006 | CN1271068C Novel method for preparing olmesartan |
| 08/23/2006 | CN1271052C Sulphonamide derivatives, the preparation thereof and the application of same as medicaments |
| 08/22/2006 | US7094904 Process for preparing monohydrate and crystal modifications of fluconazole |
| 08/22/2006 | US7094869 Animal growth regulators |
| 08/22/2006 | US7094808 Antineoplastic polyamines capable of uptake by a target cell upon administration to a human or non-human animal, and upon uptake bind via an electrostatic interaction between positively charged nitrogen and biological counter- anions |
| 08/22/2006 | US7094796 Coupling product between tryptamine and an alpha-amino acid, process for its preparation as well as its application in the neurocosmetic field |
| 08/22/2006 | US7094794 used for lowering the blood glucose and for the prevention and treatment of diabetes |
| 08/22/2006 | US7094790 containing a pyrrole ring, e.g., 4-{2-[2-(2-(R)-Methyl-pyrrolidin-1-yl)-ethyl]-benzothiazol-5-yl}-benzonitrile; useful for treating conditions and disorders related to memory and cognition processes, neurological processes, cardiovascular function, and body weight. |
| 08/22/2006 | US7094781 Sulfamides and their use as endothelin receptor antagonists |
| 08/22/2006 | US7094780 3-aminoquinazolin-2,4-dione antibacterial agents |
| 08/22/2006 | US7094779 2-(3-indolylmethyl)-1-benzoyl-4-oxime-piperazine derivatives, e.g., 1-{(2R)-1-[3,5-bis(trifluoromethyl)benzoyl]-2-(1H-indol-3-ylmethyl)-piperazin-4-yl}-2-propanone O-[2-(dimethylamino)-ethyl]oxime, used for treatment of CNS disorders. |
| 08/22/2006 | US7094778 Nervous system disorders; muscular disorders; urogenital disorders; gastrointestinal disorders; repiratory system disorders; antiallergens; side effect reduction |
| 08/22/2006 | US7094777 5-HT2A receptor ligands |
| 08/22/2006 | CA2270301C Hydroxyindoles, their use as inhibitors of phosphodiesterase 4, and processes for their preparation |
| 08/22/2006 | CA2242102C Quinazoline derivatives as antitumor agents |
| 08/17/2006 | WO2006086657A1 Process for preparing 2,3-disubstituted indoles |
| 08/17/2006 | WO2006085685A1 Pyrazole compound |
| 08/17/2006 | WO2006084882A2 Substituted 4-(indol-3-yl)quinazolines and their use |
| 08/17/2006 | WO2006084854A2 [1,2,4]-dithiazoli(di)ne derivatives, inducers of gluthathione-s-transferase and nadph quinone oxido-reductase, for prophylaxis and treatment of adverse conditions associated with cytotoxicity in general and apoptosis in particular |
| 08/17/2006 | WO2006076646A3 Heteroaryl substituted quinolin-4-ylamine analogues |
| 08/17/2006 | WO2006060122A9 Cardiotonic compounds with inhibitory activity against beta-adrenergic receptors and phosphodiesterase |
| 08/17/2006 | WO2006055734A3 3-phenyl-pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
| 08/17/2006 | WO2005107762A3 Certain chemical entities, compositions, and methods |
| 08/17/2006 | WO2005086895A3 Ion channel modulators |
| 08/17/2006 | US20060183917 Processes and compounds for the preparation of substituted naphthylindole derivatives |
| 08/17/2006 | US20060183916 By direct ortho-metallation of (tetrazol-5- gamma l)benzene; useful intermediates for the preparation of angiotensin II antagonists used, for example, in the treatment of hypertension, anxiety, glaucoma and heart failure; provides high yields, is less costly than known procedures |
| 08/17/2006 | US20060183902 Dihydroindolyl methanones as alpha 1a/1d adrenoreceptor modulators for the treatment of benign prostatic hypertrophy and lower urinary tract symptoms |
| 08/17/2006 | US20060183901 Crystalline form of an indazole-carboxamide compound |
| 08/17/2006 | US20060183897 Biaryl substituted triazoles as sodium channel blockers |
| 08/17/2006 | US20060183785 For the treatment of pain; epilepsy, manic depression, bipolar disorder, depression, anxiety and diabetic neuropathy; 5-Methyl-1-[2'-(trifluoromethoxy)-1,1'-biphenyl-3-yl]-1H-pyrazole-3-carboxamide |
| 08/17/2006 | US20060183784 Human growth hormone antagonists |
| 08/17/2006 | US20060183780 Lipoxygenase (e.g. 15-lipoxygenase) inhbitors; less toxic; longer acting; more potent; fewer side effects; easily absorbed; higher oral bioavailability and/or lower clearance; 4-Methyl-1-(pyridine-2-sulfonyl)pyrazole-3-carboxylic acid (2-chloro-4-fluorophenyl)amide |
| 08/17/2006 | US20060183772 To inhibit tumor growth in an animal; to induce apoptosis |
| 08/17/2006 | US20060183763 Novel pyrrolidyl derivatives of heteroaromatic compounds |
| 08/17/2006 | US20060183762 3-aminoquinazolin-2,4-dione antibacterial agents |
| 08/17/2006 | US20060183752 Process for preparing 2, 3-disubstituted indoles |
| 08/17/2006 | US20060183745 Vanilloid receptor ligands and their use in treatments |
| 08/17/2006 | US20060183742 Pyrazolidine-1,2-dicarboxyldiphenylamide derivatives as coagulation factor xa inhibitors for the treatment of thromboses |
| 08/17/2006 | US20060183741 Treatment of associated conditions and disorders such as gastrointestinal reflux disorders, eating disorders leading to obesity and irritable bowel syndrome |
| 08/17/2006 | US20060183694 Serine protease inhibition via 1-{[1-(2-Methoxycarbonylamino-3,3-dimethyl-butyryl)-4-(7-methoxy-2-phenyl-quinolin-4-yloxy)-pyrrolidine-2-carbonyl]-amino}-2-vinyl-cyclopropanecarboxylic acid |
| 08/17/2006 | US20060182751 Heterocyclic-substituted bis-1,8 naphthalimide compounds, antibody drug conjugates, and methods of use |
| 08/17/2006 | US20060179586 Cationic direct dyes |
| 08/17/2006 | CA2597680A1 Process for preparing 2,3-disubstituted indoles |
| 08/17/2006 | CA2597523A1 [1,2,4]-dithiazoli(di)ne derivatives, inducers of gluthathione-s-transferase and nadph quinone oxido-reductase, for prophylaxis and treatment of adverse conditions associated withcytotoxicity in general and apoptosis in particular |
| 08/16/2006 | EP1689740A1 Pyrazolyl and imidazolyl pyrimidines |
| 08/16/2006 | EP1689739A1 Azole-based kinase inhibitors |
| 08/16/2006 | EP1689729A1 Tetronic and tetramic acids as inhibitors of beta-secrease |
| 08/16/2006 | EP1689722A2 4-aminopyrimidine derivatives for treatment of hyperproliferative disorders |
| 08/16/2006 | EP1689720A1 Pyrazolyl derivatives in the form of drugs for treating acute or chronic neuronal regressions |
| 08/16/2006 | EP1689715A1 Tubulin inhibitors |
| 08/16/2006 | EP1689710A1 Indole derivatives for use as chemical uncoupler |
| 08/16/2006 | EP1689709A1 N-sulfonyldicarboximide containing tethering compounds |
| 08/16/2006 | EP1689406A2 Heterocyclic inhibitors of mek and methods of use thereof |
| 08/16/2006 | EP1689403A2 Heteroaryl-hydrazone compounds |
| 08/16/2006 | EP1689392A1 N-heteroaryl indole carboxamides and analogues thereof, for use as glucokinase activators in the treatment of diabetes |
| 08/16/2006 | EP1689387A2 Bicyclic inhibitors of mek and methods of use thereof |
| 08/16/2006 | EP1689376A2 Diaryl urea derivatives in the treatment of protein kinase dependent diseases |
| 08/16/2006 | EP1689233A2 Bicyclic inhibitors of mek and methods of use thereof |
| 08/16/2006 | EP1487437B1 Use of selective ep4 receptor agonists for the treatment of diseases |
| 08/16/2006 | EP1259234B1 3-heteroarylidenyl-2-indolinone compounds for modulating protein kinase activity and for use in cancer chemotherapy |
| 08/16/2006 | EP1019075B9 Beta 2-adrenergic receptor agonists |
| 08/16/2006 | CN1820003A Pyrrole-2, 5-dithione derivatives as liver X receptor modulators |
| 08/16/2006 | CN1820002A Novel benzimidazole compound |
| 08/16/2006 | CN1819829A Pyrimidine-2, 4-dione derivatives as gonadotropin-releasing hormone receptor antagonists |
| 08/16/2006 | CN1817868A Group of ornidazole deriative for preventing anaerobe infection and production thereof |
| 08/16/2006 | CN1269813C Imidazolo-5-yl-2-anilino-pyrimidines as agents for inhibition of cell proliferation |
| 08/16/2006 | CN1269807C Aryl substituted piperazine for curing benign prostatauxe |
| 08/16/2006 | CN1269804C Metalloproteinase inhibitors |
| 08/15/2006 | US7091380 Bradykinin B1 antagonists or inverse agonists, for prophylaxis and therapy of pain and inflammation |
| 08/15/2006 | US7091350 Produce powerful, particularly chromatic and bright colorations, in red tones, and which are relatively unselective and are stable to outside factors |
| 08/15/2006 | US7091343 Compositions useful as inhibitors of protein kinases |
| 08/15/2006 | US7091247 urotensin antagonists; vasoactive agents |
| 08/15/2006 | US7091220 Substituted indole Mannich bases |
| 08/15/2006 | US7091204 Sulfonamides |
| 08/15/2006 | US7091201 Arylalkane-sulfonamides having endothelin-antagonist activity |
| 08/15/2006 | US7091200 adrenoceptor or G-protein coupled receptors inhibitors such as 3-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-6,7-dimethoxy-2H-benzo[1,2,4]-thiadiazine-1,1-dioxide and carriers, used for prophylaxis of urogenital disorders, or as analgesics |
| 08/15/2006 | US7091199 Thienoisoxazole phenoxy unsubstituted ethyl and propyl derivatives useful as d4 antagonists |